BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 3, 2018
View Archived Issues
Deleterious mutations in SQSTM1 cause early onset neurodegeneration
Read More
Cannabis-schizophrenia association goes both ways, but unequally
Read More
How cirrhosis drug fights Alzheimer's disease
Read More
HDAC inhibition can help in DNA repair syndrome
Read More
Methylation of MORC1 predicts depression risk in humans
Read More
RegenxBio announces development of new candidate RGX-181 for CLN2 form of Batten disease
Read More
Phase I trial of Adverum's ADVM-022 gene therapy for wAMD to begin in Q4
Read More
Initial single-dose data presented from phase I study of NasoShield
Read More
Darzalex receives approval in Europe as treatment of newly diagnosed multiple myeloma
Read More
FKBP5 strikes again: Gene variant affects risk of developing chronic pain after trauma
Read More
MAP17 levels predict sensitivity of lung adenocarcinoma to chemotherapy
Read More
Development of a universally effective influenza virus
Read More
Capella BioSience describes antibodies targeting LIGHT
Read More
Invictus Oncology patents CSF1R inhibitors
Read More
Nuclear receptor RORgammaT agonists synthesized at Fudan University
Read More
Praxis Precision Medicines discovers sodium channel protein type 8 subunit alpha blockers
Read More
Cavion divulges new calcium channel inhibitors
Read More
FDA issues complete response letter for dasotraline NDA for ADHD
Read More
European Commission approves Cablivi for acquired thrombotic thrombocytopenic purpura
Read More
Incyte studies INCAGN-02385 in phase I for advanced malignancies
Read More
New phase II trial investigates MT-3724 with GEMOX in NHL
Read More
AstraZeneca conducts first-in-human study of AZD-8154 in healthy subjects
Read More